Clinical evaluation of the efficacy of methylnaltrexone in resolving constipation induced by different opioid subtypes combined with laboratory analysis of immunomodulatory and antiangiogenic effects of methylnaltrexone

BACKGROUND: Opioid-induced constipation (OIC) is one of the major symptoms in palliative care with a prevalence of 30-50%. Methylnaltrexone for the treatment of OIC is significantly more effective than placebo, but only in about fifty percent of the patients regardless of dose increase. Dose increas...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Neefjes, Elisabeth CW, van der Vorst, Maurice JDL, Boddaert, Manon SA, Zuurmond, Wouter WA, van der Vliet, Hans J, Beeker, Aart, van den Berg, Hendrik P, van Groeningen, Cornelis J, Vrijaldenhoven, Suzan, Verheul, Henk MW
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2014
Assuntos:
Study Protocol
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4145161/
https://ncbi.nlm.nih.gov/pubmed/25165428
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1472-684X-13-42
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados